GB896940A - Healing agent for wounds of the body surface - Google Patents

Healing agent for wounds of the body surface

Info

Publication number
GB896940A
GB896940A GB5280/60A GB528060A GB896940A GB 896940 A GB896940 A GB 896940A GB 5280/60 A GB5280/60 A GB 5280/60A GB 528060 A GB528060 A GB 528060A GB 896940 A GB896940 A GB 896940A
Authority
GB
United Kingdom
Prior art keywords
glucosamine
glucosamines
phosphate
derivatives
body surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5280/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB896940A publication Critical patent/GB896940A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition for healing wounds of the body surface, in dosage unit form comprises glucosamine and/or one or more derivatives of glucosamine and a pharmaceutically acceptable carrier. Specified derivatives of glucosamine are the lower N-alkanoyl glucosamines, e.g. N-acetyl glucosamine; phosphorylated glucosamines, e.g. N-acetyl glucosamine - 6 - phosphate or glucosamine - 6 -phosphate; and salts of glucosamine with pharmaceutically-acceptable acids, e.g. hydrochloric, phosphoric, citric, gluconic, acetic or malic acid. Additional therapeutic agents specified are sources of high energy phosphorus, e.g. phosphoenolpyrivic acid and adenosine phosphates such as the mono and dephorphates; tetracycline, oxytetracycline, ascorbic acid and tyrosine. The compositions may be administered locally, orally in the form of suspensions, inaqueous glycols or sugar solutions, tablets or capsules and in particular parenterally in the form of an intravenous injection employing isotonic saline solution as carrier. Specification 819,122 is referred to. Reference has been directed by the Comptroller to Specification 856,493.
GB5280/60A 1959-02-26 1960-02-15 Healing agent for wounds of the body surface Expired GB896940A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US896940XA 1959-02-26 1959-02-26

Publications (1)

Publication Number Publication Date
GB896940A true GB896940A (en) 1962-05-23

Family

ID=22219092

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5280/60A Expired GB896940A (en) 1959-02-26 1960-02-15 Healing agent for wounds of the body surface

Country Status (1)

Country Link
GB (1) GB896940A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328258A (en) * 1962-09-10 1967-06-27 Lipha Anti-microbial therapeutics consisting of nitrofurantoin, tetracycline, and d-glucosamine
FR2473887A1 (en) * 1980-01-22 1981-07-24 Curri Sergio NOVEL USE OF GLUCOSAMINO-GLYCAN BIOCHEMICAL PRECURSORS AND RESPECTIVE PHARMACEUTICAL AND COSMETIC COMPOSITIONS
US4870061A (en) * 1986-01-29 1989-09-26 Ulrich Speck Use of N-acetylglucosamine for the therapy of degenerative joint disease and related diseases
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US6645948B2 (en) 1998-03-24 2003-11-11 George D. Petito Nutritional composition for the treatment of connective tissue
US6693188B2 (en) 2001-08-08 2004-02-17 Cargill Incorporated N-acetyl-D-glucosamine and process for producing N-acetyl-D-glucosamine
ES2255829A1 (en) * 2004-08-06 2006-07-01 Bioiberica, S.A. Use of organic glucosamine salts
EP1734821A2 (en) * 2004-04-14 2006-12-27 UAB Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US7816514B2 (en) 2001-02-16 2010-10-19 Cargill, Incorporated Glucosamine and method of making glucosamine from microbial biomass
US7923437B2 (en) 2001-02-16 2011-04-12 Cargill, Incorporated Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same
WO2011121250A2 (en) 2010-04-02 2011-10-06 Libragen Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
US8222232B2 (en) 2001-02-16 2012-07-17 Cargill, Incorporated Glucosamine and N-acetylglucosamine compositions and methods of making the same fungal biomass

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328258A (en) * 1962-09-10 1967-06-27 Lipha Anti-microbial therapeutics consisting of nitrofurantoin, tetracycline, and d-glucosamine
FR2473887A1 (en) * 1980-01-22 1981-07-24 Curri Sergio NOVEL USE OF GLUCOSAMINO-GLYCAN BIOCHEMICAL PRECURSORS AND RESPECTIVE PHARMACEUTICAL AND COSMETIC COMPOSITIONS
US4870061A (en) * 1986-01-29 1989-09-26 Ulrich Speck Use of N-acetylglucosamine for the therapy of degenerative joint disease and related diseases
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US5972999A (en) * 1997-01-22 1999-10-26 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6645948B2 (en) 1998-03-24 2003-11-11 George D. Petito Nutritional composition for the treatment of connective tissue
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US8168599B2 (en) 1998-03-24 2012-05-01 Petito George D Composition and method for healing tissues
US6676977B2 (en) 1999-08-20 2004-01-13 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US8034925B2 (en) 2001-02-16 2011-10-11 Cargill, Incorporated Glucosamine and method of making glucosamine from microbial biomass
US8222232B2 (en) 2001-02-16 2012-07-17 Cargill, Incorporated Glucosamine and N-acetylglucosamine compositions and methods of making the same fungal biomass
US7816514B2 (en) 2001-02-16 2010-10-19 Cargill, Incorporated Glucosamine and method of making glucosamine from microbial biomass
US7923437B2 (en) 2001-02-16 2011-04-12 Cargill, Incorporated Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same
US6693188B2 (en) 2001-08-08 2004-02-17 Cargill Incorporated N-acetyl-D-glucosamine and process for producing N-acetyl-D-glucosamine
EP1734821A2 (en) * 2004-04-14 2006-12-27 UAB Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
EP1734821A4 (en) * 2004-04-14 2011-07-06 Uab Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
ES2255829A1 (en) * 2004-08-06 2006-07-01 Bioiberica, S.A. Use of organic glucosamine salts
FR2958157A1 (en) * 2010-04-02 2011-10-07 Libragen COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING N-ACETYL-GLUCOSAMINE-6-PHOSPHATE
WO2011121250A2 (en) 2010-04-02 2011-10-06 Libragen Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
WO2011121250A3 (en) * 2010-04-02 2011-11-17 Libragen Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
CN102905680A (en) * 2010-04-02 2013-01-30 莱博睿金公司 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
US9907760B2 (en) 2010-04-02 2018-03-06 Libragen Cosmetic and pharmaceutical composition comprising N-acetylglucosamine-6-phosphate

Similar Documents

Publication Publication Date Title
GB896940A (en) Healing agent for wounds of the body surface
Nilsson et al. Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA): A double blind investigation
SE7413349L (en)
MY113803A (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as medicament or diagnostic, and medicament containing them.
KR910005858A (en) Fatty acid therapy
ES369528A1 (en) Naphthacene derivatives
GB2000025A (en) Nitroimidazole formulations
ES8301631A1 (en) An orally administered drug form comprising a glycosidic antibiotic and an adjuvant.
GB1153640A (en) A Carnitin Salt
GB1270049A (en) New pharmaceutical product
GB945772A (en) A derivative of cobalamin
CN114588118B (en) Sodium aescinate compound preparation for injection
GB1072359A (en) Pyrazolone derivatives and pharmaceutical compositions containing them
HUT48265A (en) Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components
FR2403079A1 (en) Formulation for the treatment of cancer - contains a mono, di or tri:esterified glycyrrhetinic acid which acts as a neoplastic and cytostatic agent
GB782469A (en) Anti-t.b. factor
GB1088455A (en) Method and composition for reducing plasma lipid levels
NO933017L (en) Procedure for the safe administration of fatty acid
ES348538A1 (en) N-Substituted Noratropinium Salts
US2143829A (en) Water soluble derivative of p-aminobenzenesulphonamide
GB828729A (en) Therapeutic compositions containing novobiocin
GB1246315A (en) Pharmaceutical compositions
IT1247093B (en) SALINE DERIVATIVES OF GLYCERYL PHOSPHORYL MYINOSITOL FOR THERAPEUTIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
GB1036314A (en) Injectable solution of acetylsalicylic acid
GB1092185A (en) A salt of a nitrogen-containing ester of phosphoric acid and the therapeutic applications thereof